- Chemical and structural lessons from recent successes in protein–protein interaction inhibition (2P2I)
Xavier Morelli et al, 2011, Current Opinion in Chemical Biology CrossRef - A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors
Gordana Vlahovic et al, 2014, Investigational New Drugs CrossRef - 2P2I HUNTER : a tool for filtering orthosteric protein–protein interaction modulators via a dedicated support vector machine
Véronique Hamon et al, 2014, Journal of The Royal Society Interface CrossRef - Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis
Kevin Tan et al, 2013, Journal of Cancer Research and Clinical Oncology CrossRef - Targeting Src family kinases in anti-cancer therapies: turning promise into triumph
Siyuan Zhang et al, 2012, Trends in Pharmacological Sciences CrossRef - Leading Small Molecule Inhibitors of Anti-Apoptotic Bcl-2 Family Members
Victor Y. Yazbeck et al, 2013, Cell Death Signaling in Cancer Biology and Treatment CrossRef - A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
Anthony W. Tolcher et al, 2014, Cancer Chemotherapy and Pharmacology CrossRef - Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors
Girieca Lorusso et al, 2020, Frontiers in Oncology CrossRef - WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors
Yuji Sakuma et al, 2012, Laboratory Investigation CrossRef - Bcl‐2 family in non‐small cell lung cancer: its prognostic and therapeutic implications
Ping‐Li Sun et al, 2017, Pathology International CrossRef - Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps
Lubna Danish et al, 2018, PLOS ONE CrossRef - BH3-mimetics: recent developments in cancer therapy
Paul A. Townsend et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef - Mcl-1 downregulation by YM155 contributes to its synergistic anti-tumor activities with ABT-263
Haikuo Tang et al, 2011, Biochemical Pharmacology CrossRef - Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies
Jing Wang et al, 2022, Cancers CrossRef